| Viruses | |
| B19V | human parvovirus B19 |
| EBOV | ebola virus |
| EMCV-D | encephalomyocarditis virus |
| HBV | hepatitis B virus |
| HCMV | human cytomegalovirus |
| HCV | hepatitis C virus |
| HIV-1 | human immunodeficiency virus type 1 |
| HPV | human papillomavirus |
| HSV-1 | herpes simplex virus 1 |
| HSV-2 | herpes simplex virus 2 |
| IAV | influenza A virus |
| IBV | infectious bronchitis virus |
| JEV | Japanese encephalitis virus |
| LCMV | lymphocytic choriomeningitis virus |
| MV | measles virus |
| SARS-CoV | severe acute respiratory syndrome corona virus |
| SFV | Semliki Forest virus |
| SV40 | simian virus 40 |
| VSV | vesicular stomatitis virus |
| WNV | West Nile virus |
| ZIKV | Zika virus |
| Sphingolipids and sphingolipid-metabolizing enzymes | |
| α-CalCer | α-galactosylceramide |
| ASM | acid sphingomyelinase |
| CERT | ceramide transport protein |
| dhS1P | dihydrosphingosine 1-phosphate |
| FIASMA | functional inhibitor of acid sphingomyelinase |
| GalCer | galactosylceramide |
| Gb3 | globotriaosylceramide |
| Gb4Cer | globoside/globotetraosylceramide |
| GlcCerS | glucosylceramide synthase |
| GM3-NeuAc | N-acetylneuraminyllactosylceramide |
| GSL | glycosphingolipids |
| NSM | neutral sphingomyelinase |
| SM | sphingomyelin |
| SMS2 | sphingomyelin synthase 2 |
| SphK1 | sphingosine kinase 1 |
| SPT | serine palmitoyltransferase |
| Other | |
| ACE2 | angiotensin converting enzyme 2 |
| COVID-19 | corona virus disease 2019 |
| DC-SIGN | dendritic cell-specific intracellular adhesion molecule-3-grabbing non-integrin |
| HA | hemagluttinin |
| iNKT | invariant natural killer T cell |
| mTOR | mammalian target of rapamycin |
| OSBP | oxysterol-binding protein |
| PKD | protein kinase D |
| RanBP3 | Ran-binding protein 3 |
| TGN | trans golgi network |